Abstract:Angiogenesis is one of the most essential events during embryonic development. The previous studies proved that MEKK3 (MAP3K3) is critical for angiogenesis. However, precisely how MEKK3 regulates the vascular development remains largely unknown. To investigate the impact of MEKK3 in vascular development in vivo and its role in normal physiological and pathological settings, we generated VE-Cadherin CreERT2;MEKK3 flox/+ (control) and VE-Cadherin CreERT2;MEKK3 flox/- (MEKK3 iEC -/-) mice. MEKK3 deletion was induced from postnatal day (P) 1 by administration of tamoxifen daily. The retinal angiogenesis model was used to analyze the blood vessel development in P7 and P12 mice. Whole-mount staining of P7 retinas in MEKK3 iEC -/- mutants showed a significant decrease in vascularized area and branch formation. In contrast, control pups, although only having one copy of the MEKK3 gene in endothelial cells, developed a complete vascular sheet at the same dose of tamoxifen, as did the untreated pups. At P12, MEKK3 iEC -/- mice showed defects in vessel remodeling and arterial patterning. These retinas had dilated and tortuous arteries losing the identical marker. This phenotype accorded with the pathology of AVM (arteriovenous malformation). We then cultured murine aortic rings in 3D matrigel and induced sprouting with VEGF. Administration of TGF-b receptor kinase inhibitor SB431542 to the MEKK3 iEC-/- aorta showed a partial rescue effect on the number of sprouts and vascularized area. It implicated that the vascular malformation in the MEKK3 iEC-/- mice was partially due to the elevated TGF-b signals in endothelial cells. We confirmed the result by staining the retinas with SMA and N-cadherin, which are the downstream genes in TGF-b pathway. It turned out that both SMA and N-cadherin were expressed stronger in MEKK3 iEC-/- retinas than in the control ones. Next, by in vitro studies, we found that endothelial cell activation by VEGF treatment led to rapid and strong phosphorylation of R-SMADs at the linker regions in the control endothelial cells. Such phosphorylation was severely impaired in the MEKK3 -/- endothelial cells. The same results were found in the activation of ERK1/2 and p38. Inhibition of ERK1/2 but not p38 MAPK in control endothelial cells greatly reduced the VEGF-induced phosphorylation of R-SMADs at their linker regions. Inhibition of both ERK1/2 and p38 did not further reduce the SMAD linker region phosphorylation compared to inhibition of ERK1/2. Thus, we determined ERK1/2 are responsible for the VEGF-induced, MEKK3-dependent phosphorylation of R-SMADs at the linker region. Finally, since Notch pathway is an evolutionarily conserved signaling , which directly affects angiogenesis, we used aortic ring model to test their interaction, and detected the gene expression in endothelial cells. Hey1 and Hey2 were over expressed in MEKK3 -/- endothelial cells. Knockdown of Hey1 and Hey2 could rescue the deficient angiogenesis. Knockdown of RBPJ did not affect MEKK3 mediated angiogenesis or induction of Hey1 and Hey2. The above data supported a model whereby MEKK3-mediated SMAD signaling induces HEY1 and HEY2 independently of canonical Notch activation. Disclosures No relevant conflicts of interest to declare.

E-Prostanoid 3 Receptor Mediates Sprouting Angiogenesis Through Suppression of the Protein Kinase A/β-Catenin/Notch Pathway

A Role for Planar Cell Polarity Signaling in Angiogenesis

The Role of RhoA in Neovascular-Related Functions of Endothelial Progenitor Cells Induced by AngiotensinⅡ

MEKK3 Regulates Angiogenesis Through Smad Signaling

Angiotensin-converting Enzyme Inhibitor Promotes Angiogenesis Through Sp1/Sp3-mediated Inhibition of Notch Signaling in Male Mice.

Targeted Disruption of the Prostaglandin E2 E-prostanoid 2 Receptor Exacerbates Vascular Neointimal Formation in Mice.

CXCR3-CXCL11 Signaling Restricts Angiogenesis and Promotes Pericyte Recruitment

Regulation of Vasculogenesis and Angiogenesis by EphB/ephrin-B2 Signaling Between Endothelial Cells and Surrounding Mesenchymal Cells

Endothelial S1pr2 regulates post-ischemic angiogenesis via AKT/eNOS signaling pathway

Genetic reduction of vascular endothelial growth factor receptor 2 rescues aberrant angiogenesis caused by epsin deficiency.

Elevated Expression of Mir302-367 in Endothelial Cells Inhibits Developmental Angiogenesis Via CDC42/CCND1 Mediated Signaling Pathways

Comparative Phosphoproteomics Analysis of VEGF and Angiopoietin-1 Signaling Reveals ZO-1 As a Critical Regulator of Endothelial Cell Proliferation*

HtrA3‐Mediated Endothelial Cell–Extracellular Matrix Crosstalk Regulates Tip Cell Specification

The ER membrane protein complex subunit Emc3 controls angiogenesis via the FZD4/WNT signaling axis

Regulation of retinal angiogenesis by phospholipase C-β3 signaling pathway

GPR126 Protein Regulates Developmental and Pathological Angiogenesis Through Modulation of VEGFR2 Receptor Signaling*

ASSA13-10-14 Cellular Repressor of E1A-Stimulated Genes Accelerates Endothelial Angiogenesis Via Integrin-Linked Kinase-PINCH-CDC42 Activation

Control of endothelial cell function and arteriogenesis by MEG3:EZH2 epigenetic regulation of integrin expression

Inactivation of the E-prostanoid 3 Receptor Attenuates the Angiotensin II Pressor Response Via Decreasing Arterial Contractility.

ANGPTL3 Stimulates Endothelial Cell Adhesion and Migration Via Integrin Αvβ3 and Induces Blood Vessel Formation in Vivo

Endothelial G protein stimulatory alpha-subunit is a critical regulator of post-ischemic angiogenesis